Literature DB >> 17470511

The emerging role of FOXO transcription factors in pancreatic beta cells.

Dominique A Glauser1, Werner Schlegel.   

Abstract

FOXO transcription factors critically control fundamental cellular processes, including metabolism, cell differentiation, cell cycle arrest, DNA repair, and other reactions to cellular stress. FOXO factors sense the balance between stimuli promoting growth and differentiation versus stress stimuli signaling damage. Integrated through the FOXO system, these divergent stimuli decide on cell fate, a choice between proliferation, differentiation, or apoptosis. In pancreatic beta cells, most recent evidence highlights complex FOXO-dependent responses to glucose, insulin, or other growth factors, which include regulatory feedback. In the short term, FOXO-dependent mechanisms help beta cells to accomplish their endocrine function, and may increase their resistance to oxidative stress due to transient hyperglycemia. In the long term, FOXO-dependent responses lead to the adaptation of beta cell mass, conditioning the future ability of the organism to produce insulin and cope with changes in fuel abundance. FOXO emerges as a key factor for the maintenance of a functional endocrine pancreas and represents an interesting element in the development of therapeutic approaches to treat diabetes. This review on the role of FOXO transcription factors in pancreatic beta cells has three parts. In Part I, FOXO transcription factors will be presented in general: structure, molecular mechanisms of regulation, cellular functions, and physiological roles. Part II will focus on specific data about FOXO factors in pancreatic beta cells. Lastly in Part III, it will be attempted to combine general and beta cell-specific knowledge with the aim to envisage globally the role of FOXO factors in beta cell-linked physiology and disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470511     DOI: 10.1677/JOE-06-0191

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  52 in total

1.  The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways.

Authors:  Anaïs Perilhou; Cécile Tourrel-Cuzin; Ilham Kharroubi; Carole Henique; Véronique Fauveau; Tadahiro Kitamura; Christophe Magnan; Catherine Postic; Carina Prip-Buus; Mireille Vasseur-Cognet
Journal:  Mol Cell Biol       Date:  2008-09-02       Impact factor: 4.272

Review 2.  The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue.

Authors:  D Gerace; R Martiniello-Wilks; B A O'Brien; A M Simpson
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

3.  DAF-16/Forkhead box O transcription factor: many paths to a single Fork(head) in the road.

Authors:  Kelvin Yen; Sri Devi Narasimhan; Heidi A Tissenbaum
Journal:  Antioxid Redox Signal       Date:  2010-11-30       Impact factor: 8.401

4.  FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.

Authors:  Carly Kibbe; Junqin Chen; Guanlan Xu; Gu Jing; Anath Shalev
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

5.  Identification of direct forkhead box O1 targets involved in palmitate-induced apoptosis in clonal insulin-secreting cells using chromatin immunoprecipitation coupled to DNA selection and ligation.

Authors:  H Y Lin; Y Yin; J X Zhang; H Xuan; Y Zheng; S S Zhan; Y X Zhu; X Han
Journal:  Diabetologia       Date:  2012-07-20       Impact factor: 10.122

6.  Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.

Authors:  Xuefen Xie; Hailing Liao; Huaixin Dang; Wei Pang; Youfei Guan; Xian Wang; John Y-J Shyy; Yi Zhu; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2009-01-29

7.  Detection of expressional changes induced by intrauterine growth restriction in the developing rat pancreas.

Authors:  Lin Zhang; Wei Chen; Yuee Dai; Ziyang Zhu; Qianqi Liu
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-17

Review 8.  Growth factor control of pancreatic islet regeneration and function.

Authors:  Anke Assmann; Charlotte Hinault; Rohit N Kulkarni
Journal:  Pediatr Diabetes       Date:  2008-09-19       Impact factor: 4.866

9.  Transgenic expression of insulin-response element binding protein-1 in beta-cells reproduces type 2 diabetes.

Authors:  Betty C Villafuerte; Michelle T Barati; Ying Song; Joseph P Moore; Paul N Epstein; Jessica Portillo
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

10.  Overexpression of kinase-negative protein kinase Cdelta in pancreatic beta-cells protects mice from diet-induced glucose intolerance and beta-cell dysfunction.

Authors:  Anita M Hennige; Felicia Ranta; Isabel Heinzelmann; Martina Düfer; Diana Michael; Heidi Braumüller; Stefan Z Lutz; Reiner Lammers; Gisela Drews; Fatima Bosch; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetes       Date:  2009-10-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.